Attorneys Seek $22M In Fees For Pfizer Settlement

Law360, New York (February 8, 2011, 1:59 PM EST) -- The plaintiffs’ counsel in a shareholder class action against Pfizer Inc. executives over an allegedly fraudulent marketing campaign have asked a judge to sanction $22 million in attorneys’ fees as part of the final approval of a $75 million settlement.

The hefty fee award is warranted by both the significant cash value of the settlement and governance changes the settlement agreement will enact at the company, the attorneys said in a motion for final approval of the settlement, filed Monday in the U.S. District Court for...
To view the full article, register now.




Case Information

Case Title

In re Pfizer Inc. Shareholder Derivative Litigation

Case Number



New York Southern

Nature of Suit

Other Statutory Actions


Jed S. Rakoff

Date Filed

September 10, 2009

Law Firms


UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.